INTRODUCTION
Although transurethral resection of prostate (TURP) has become the 'gold standard' for surgical treatment of benign prostatic hypertrophy, sexual changes after TURP, including ED and retrograde ejaculation, remain a problem. The occurrence of post-TURP ED was about 14%. 1 With increasing improvement in the treatment of ED, including the use of oral inhibitor PDE5, the success rate of ED treatment has been increased significantly, thus helping ED patients recover their impaired sexual life greatly. From June 2006 to June 2010, we used Tadalafil to treat patients with post-TURP ED and obtained satisfactory outcomes.
MATERIALS AND METHODS

Clinical data
A total of 104 male patients who experienced ED after TURP were randomly assigned into the therapy group and matched group on the basis of degree of ED. In therapy group, the age range was from 53.2 to 78.7 years, with a mean of 66.5. In matched group, the age range was from 53.7 to 77.9 years, with a mean of 66.2. There were no differences in the time length since TURP between the two groups. Inclusion criteria were patients whose preoperative 5-item version of the International Index of Erectile Function (IIEF-5) score was X22 and postoperative IIEF-5 score was o22, 3 months after TURP between July 1996 and June 2010. According to IIEF-5 criteria for judging the presence or absence of ED and the degree of ED, 2 the degree of ED was assessed as follows: score 5 --7 ¼ severe degree, 8 --11 ¼ moderate degree, 12 --16 ¼ mild-to-moderate degree, and 17 --21 ¼ mild degree. Each group included four cases of severe-degree ED, 12 cases of moderate-degree ED, 18 cases of mild-to-moderate-degree ED, and 18 cases of mild-degree ED. The results of nocturnal penile tumescence testing performed after surgery showed that, of the 52 patients in therapy group, 36 patients suffered from organic ED and 16 suffered from psychological ED; in the matched group, 33 patients suffered from organic ED and 19 suffered from psychological ED.
Treatment methods
The inclusion criteria included the absence of ED symptoms before TURP and the presence of ED 3 months after TURP. Drug administration was initiated from 10 mg, and increased to 20 mg by week 2 and 4, depending on the therapeutic effect and adverse reactions. There were 6, 10, 8 and 4 patients (totally 28) in mild, mild-to-moderate, moderate and severe group, respectively, received 20 mg dose finally. In the therapy group, Tadalafil was administered about 1 h before sexual activity, at least once a week, and the interval between two doses was at least 24 h. The patients were informed that there should be sexual stimulation after drug administration. The therapeutic effect of Tadalafil was assessed by comparing IIEF-5 scores before treatment and those obtained at the end of 8-week treatment or the last follow-up visit, and by the result of nocturnal penile tumescence testing. In the matched group, the patients were given placebo of starch made with the same look as Tadalafil pills. The patients in the matched group were informed with the same administration procedure as the therapy group.
The criteria for assessment of the therapeutic effects
The treatment was considered very good if post-treatment IIEF-5 score was X22, erection was sufficiently hard, intercourse and ejaculation were completed successfully, and the wife was satisfied. The treatment was considered good if erection was not hard enough, intercourse and ejaculation were completed at a baseline level, and the wife was basically satisfied. Effective treatment occurred when IIEF-5 score was 415, or there was a 10-point increase against the original score. Ineffective treatment occurred when the penis was not hard enough and became soft right after insertion without ejaculation, or there was a less than 5-point increase against the original score. The effective rate was calculated on the basis of very good and good therapeutic effects. Changes in IIEF-5 score before and after medical treatment were compared.
Statistical analysis IIEF-5 scores before and after treatments were recorded as x ± s. Statistical analysis was performed by SPSS 10.0 software, and comparisons between groups were conducted with Student's t-test. Po0.05 was considered statistically significant.
RESULTS
Of the 52 patients in the treatment group, 28 patients were cured, 17 patients responded to the treatment, and 7 patients failed to respond to the treatment. The overall effective rate was 86.5%. Of the other 52 patients in the matched group, 6 patients were cured, 7 patients responded to the treatment, and 39 patients failed to respond to the treatment. The overall effective rate was 25%. The scores for IIEF problem 3 (insertion frequency), problem 4 (maintenance of erection state) and problem 7 (the degree of intercourse satisfaction) were raised significantly (Po0.05; Tables 1 and 2 ).
The results of the nocturnal penile tumescence testing performed at the end of the 8-week treatment showed that, of the 52 patients in therapy group, 14 patients suffered from organic ED and 38 suffered from psychological ED; in the matched group, 29 patients suffered from organic ED and 23 suffered from psychological ED.
DISCUSSION
The etiology of ED is complex. Any surgical injury to penile nerve distribution, blood supply and the source of androgen, as well related psychological influences, may result in ED. There are various treatments for ED, including psychological therapy, oral administration of medications, vacuum therapy systems, intracavernous injection and surgery. Each treatment has its respective indications. Most patients (73.8%) tend to choose oral medications due to convenience in use and few adverse reactions. 3 Tadalafil is a PDE5 inhibitor approved in recent years for the clinical treatment of ED. It inhibits decomposition of cGMP in the penis by inhibiting PDE5, thus increasing the cGMP level, 4,5 enhancing the action of endogenous NO and relaxing the penile arterial smooth muscle so as to enable the penis to obtain high blood flow and filling for complete erection. Under the action of sexual stimulation, vascular endothelial cells and non-adrenergic noncholinergic nerves release NO. This is the reason why Tadalafil can only work effectively in the presence of sexual stimulation. 6 Tadalafil has a longer half-life (17.5 h) than that of Sildenafil and Vardenafil, and is effective within 36 min to 36 h after oral administration. Brock et al. 7 reported that the success rate of intercourse attempts was 73 --80% within 30 min to 36 h after oral administration of 20 mg Tadalafil. A multi-center open-label study observed the responses of patients of different ages with different courses of disease, severities and etiologies of ED, smoking histories and associated diseases (diabetes, hypertension, hyperlipidemia, cardiovascular disease and benign prostatic hypertrophy) to 10 and 20 mg Tadalafil after a 12-week treatment. 8 The results showed that IIEF-5 scores of erection function improved significantly in both the 10 and 20 mg Tadalafil treatment groups. As Tadalafil can improve erection function within a long period, it is not necessary to deliberately plan the time and place of sexual activities. This arbitrariness is consistent with the demand of patients for 'natural, happy and normal sexual life', and helps patients restore their confidence in life. The overall effective rate of oral administration of Tadalafil in the 52 TURP patients of the present series was 86.5%, but the overall effective rate of oral placebo was 25%. The statistical difference was significant (Po0.05) between two groups, suggesting that Tadalafil therapy was satisfactory.
It is very interesting that in mild and mild-to-moderate ED groups, the placebo treatment showed negligible effects ( Table 2) . Post-TURP decrease in sexual function may be caused by thermal injury to the erectile nerves when the thermal effect of TURP passes across the envelope, exudation of the intra-operative irrigation solution, formation of hematoma or disordered blood supply, and psychological factors. 5,9 --11 It is possible that the placebo treatments are more effective on psychological aspects of ED, and are therefore less effective to the organic injury caused by TURP surgery. On the other hand, Tadalafil administration showed improvement in organic rehabilitation in animal models of ED with nerve transection, 12 suggesting its efficiency in targeting TURP types of ED.
Oral administration of the recommended dose of Tadalafil may produce some adverse reactions, 13 including the following: headache in 11 --15% patients; indigestion in 8 --10% patients; backache 12 --24 h after drug administration in 5 --6% patients, which may last as long as 48 h, though 3% patients who were administered with placebos also developed backache; and influence on vision and color sensation in about 0.1% patients. But no such adverse reaction was noticed in our patients. This may be due to good medical compliance of our patients, and the total dosage was relatively low in our study.
In summary, as most TURP-induced ED patients are old and often complicated with some chronic medical problems, clinical treatment of such patients is often challenging. The safety and effectiveness of Tadalafil are consistent with its indications of treatment, and thus can be used as the first-line medication.
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